| HOME >> MEDICINE >> TECHNOLOGY |
Figure 26: GPCRs in Drug Discovery, Ophthalmology, Number of Molecules Targeting GPCRs By Phase, 2011 78
Figure 27: GPCRs in Drug Discovery, Ophthalmology, Top 10 Indications By Total Molecules In Pipeline, 2011 79
Figure 28: GPCRs in Drug Discovery, Genito-Urinary System and Sex Hormones, Number of Molecules Targeting GPCRs By Phase, 2011 82
Figure 29: GPCRs in Drug Discovery, Genito-Urinary System and Sex Hormones, Top 10 Indications By Total Molecules In Pipeline, 2011 83
Figure 30: GPCRs in Drug Discovery, Top 10 Indications By Total Molecules in Pipeline, 2011 85
Figure 31: GPCRs in Drug Discovery, Top 10 Indications By Phase, 2011 87
Figure 32: GPCRs in Drug Discovery, Diabetes, Number of Molecules Targeting GPCRs By Phase, 2011 88
Figure 33: GPCRs in Drug Discovery, Diabetes, Major Targets for Pipeline Molecules, 2011 89
Figure 34: GPCRs in Drug Discovery, Diabetes, Comparison of Major Targets with Stage of Development, 2011 90
Figure 35: GPCRs in Drug Discovery, Parkinson's Disease, Number of Molecules Targeting GPCRs By Phase, 2011 91
Figure 36: GPCRs in Drug Discovery, Parkinson's Disease, Major Targets for Pipeline Molecules, 2011 92
Figure 37: GPCRs in Drug Discovery, Parkinson's Disease, Comparison of Major Targets with Stage of Development, 2011 93
Figure 38: GPCRs in Drug Discovery, Pain, Number of Molecules Targeting GPCRs By Phase, 2011 94
Figure 39: GPCRs in Drug Discovery, Pain, Major Targets for Pipeline Molecules, 2011 95
Figure 40: GPCRs in Drug Discovery, Pain, Comparison of Major Targets with Stage of Development, 2011 96
Figure 41: GPCRs in Drug Discovery, Schizophrenia, Number of Molecules Targeting GPCRs By Phase, 2011 97
Figure 42: GPCRs in Drug Discovery, Schizophrenia, Major Targets for Pipeline Molecules, 201
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |